Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/29260
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hughes C.M. | en |
dc.contributor.author | Dendle C. | en |
dc.contributor.author | Radalage R. | en |
dc.contributor.author | Spring S. | en |
dc.contributor.author | Graham M. | en |
dc.contributor.author | Rogers B.A. | en |
dc.date.accessioned | 2021-05-14T09:52:51Z | en |
dc.date.available | 2021-05-14T09:52:51Z | en |
dc.date.copyright | 2020 | en |
dc.date.created | 20200526 | en |
dc.date.issued | 2020-05-26 | en |
dc.identifier.citation | Pathology. 52 (4) (pp 478-482), 2020. Date of Publication: June 2020. | en |
dc.identifier.issn | 0031-3025 | en |
dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/29260 | en |
dc.description.abstract | Multiplex polymerase chain reaction (PCR) testing has revolutionised microbiological practice but also increased the number of positive results of uncertain significance. This phenomenon has been seen in the increasing detection of cytomegalovirus (CMV) in mucocutaneous swabs for herpesviruses, the microbiological significance of which is a priori unclear. The aim of our study was to determine if an incidental finding of a positive CMV result represented CMV disease, if it facilitated a timely diagnosis of CMV disease or whether there were any deleterious outcomes. We performed a retrospective review of patients with an incidentally positive PCR result for CMV on external and mucosal swabs, including medical comorbidities and presence of immunosuppression, subsequent investigations, whether a diagnosis of CMV disease was made, and treatment. CMV detection was infrequent, detected in 158 (3.4%) of 4626 herpes multiplex PCR tests performed. The majority (60.4%) of patients were immunocompromised, and amongst these patients a positive swab represented a new diagnosis or already known CMV disease in 14%. In seven patients (5%), all of whom were immunocompromised, the positive CMV PCR on a swab led to further investigation and subsequent diagnosis and treatment of CMV disease. Whilst not recommended for diagnosis of CMV disease, if CMV is detected on a mucocutaneous swab in an immunocompromised patient, further assessment and investigation for CMV disease should be undertaken.Copyright © 2020 Royal College of Pathologists of Australasia | en |
dc.language | en | en |
dc.language | English | en |
dc.publisher | Elsevier B.V. | en |
dc.relation.ispartof | Pathology | en |
dc.subject.mesh | aged | - |
dc.subject.mesh | bullous pemphigoid | - |
dc.subject.mesh | cancer combination chemotherapy | - |
dc.subject.mesh | Cytomegalovirus | - |
dc.subject.mesh | cytomegalovirus infection | - |
dc.subject.mesh | diagnostic test accuracy study | - |
dc.subject.mesh | diffuse large B cell lymphoma | - |
dc.subject.mesh | immunocompromised patient | - |
dc.subject.mesh | immunosuppressive treatment | - |
dc.subject.mesh | incidental finding | - |
dc.subject.mesh | infant | - |
dc.subject.mesh | liver failure | - |
dc.subject.mesh | liver failure [Surgery] | - |
dc.subject.mesh | liver transplantation | - |
dc.subject.mesh | lupus erythematosus nephritis | - |
dc.subject.mesh | medical record | - |
dc.subject.mesh | mouth ulcer | - |
dc.subject.mesh | mucus | - |
dc.subject.mesh | multiplex polymerase chain reaction | - |
dc.subject.mesh | newborn | - |
dc.subject.mesh | palliative therapy | - |
dc.subject.mesh | pathologist | - |
dc.subject.mesh | pemphigus vulgaris | - |
dc.subject.mesh | rheumatoid arthritis | - |
dc.subject.mesh | school child | - |
dc.subject.mesh | prednisolone | - |
dc.subject.mesh | valganciclovir | - |
dc.subject.mesh | polymerase chain reaction system | - |
dc.subject.mesh | mucosal swab | - |
dc.subject.mesh | 2012-15 AusDiagnostics Easy-Plex 12-well assay | - |
dc.subject.mesh | 2015-16 AusDiagnostics High-Plex Herpes, Enterovirus and Adenovirus 16-well assay | - |
dc.subject.mesh | antiviral therapy | - |
dc.subject.mesh | skin biopsy | - |
dc.subject.mesh | skin injury | - |
dc.subject.mesh | smear | - |
dc.subject.mesh | statistically significant result | - |
dc.subject.mesh | systemic disease | - |
dc.subject.mesh | T cell lymphoma | - |
dc.subject.mesh | very elderly | - |
dc.subject.mesh | virus detection | - |
dc.subject.mesh | azathioprine | - |
dc.subject.mesh | mycophenolic acid | - |
dc.subject.mesh | cyclophosphamide plus doxorubicin plus etoposide plus prednisolone plus rituximab plus vincristine | - |
dc.subject.mesh | cyclophosphamide plus doxorubicin plus prednisolone plus rituximab plus vincristine | - |
dc.subject.mesh | ganciclovir | - |
dc.subject.mesh | methotrexate | - |
dc.title | Incidental mucocutaneous cytomegalovirus detection and its predictive value for systemic disease. | en |
dc.type | Article | en |
dc.identifier.affiliation | Infectious Diseases and Clinical Microbiology | - |
dc.identifier.affiliation | Pathology | - |
dc.identifier.affiliation | Infectious Diseases and Clinical Microbiology | - |
dc.identifier.doi | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/j.pathol.2020.02.009 | - |
dc.publisher.place | United States | en |
dc.identifier.pubmedid | 32354659 [http://www.ncbi.nlm.nih.gov/pubmed/?term=32354659] | en |
dc.identifier.source | 2005700745 | en |
dc.identifier.institution | (Hughes, Spring, Radalage, Graham, Dendle, Rogers) Monash Infectious Diseases, Monash Medical Centre, Monash Health, Clayton, Victoria, Australia (Hughes, Graham) Department of Microbiology, Monash Pathology, Monash Health, Clayton, Victoria, Australia (Dendle, Rogers) Centre for Inflammatory Diseases, Monash University, Melbourne, Victoria, Australia | en |
dc.description.address | C.M. Hughes, c/o Monash Infectious Diseases, Monash Medical Centre, 246 Clayton Road, Clayton, Vic 3168, Australia. E-mail: carly_m_hughes@yahoo.com.au | en |
dc.description.publicationstatus | Embase | en |
dc.rights.statement | Copyright 2020 Elsevier B.V., All rights reserved. | en |
dc.subect.keywords | Cytomegalovirus immunocompromised host | en |
dc.identifier.authoremail | Hughes C.M.; carly_m_hughes@yahoo.com.au | en |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.openairetype | Article | - |
crisitem.author.dept | Infection Prevention and Epidemiology | - |
crisitem.author.dept | Infectious Diseases and Clinical Microbiology | - |
crisitem.author.dept | Infectious Diseases and Clinical Microbiology | - |
crisitem.author.dept | Infectious Diseases and Clinical Microbiology | - |
Appears in Collections: | Articles |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.